Spots Global Cancer Trial Database for Moderate Hypofractionated Boost to the Prostate With Pelvic RT in High Risk Prostate Cancer

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Trial Identification

Brief Title: Moderate Hypofractionated Boost to the Prostate With Pelvic RT in High Risk Prostate Cancer

Official Title: Moderate Hypofractionated Boost to the Prostate With Pelvic RT in High Risk Prostate Cancer

Study ID: NCT05313815

Conditions

Prostate Cancer

Interventions

Moderate hypofractionated boost to the prostate with pelvic RT (external beam radiotherapy)

Study Description

Brief Summary: This is a single-arm phase II prospective trials that is recruiting 100 participants. The study population that is being investigated are patients with localized high-risk or node-positive prostate cancer. Participants will receive external beam radiotherapy as a moderately hypofractionated boost to the prostate with pelvic radiation therapy. Androgen deprivation therapy will be prescribed at the discretion of the treating physician as per standard of care.

Detailed Description: